Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance

Learn more about:
Related Clinical Trial
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance Integrated Cancer Repository for Cancer Research Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer Internet-based System for Cancer Patients to Self-report Toxicity Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy Lymphoscintigraphy in Patients With Vaginal Cancer Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer Pelvic Fractures and Radiation Therapy for Cervical Cancer Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer

Brief Title

Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance

Official Title

Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance

Brief Summary

      This study aims to learn about the needs and feelings of women who are infertile. Being
      infertile means not being able to have a child without the help of a third party. There are
      other options for building a family. The researchers are interested in the participants'
      thoughts about these options and want to learn about the experiences of infertile women due
      to cancer treatment as well as women who are infertile due to other causes. The researchers
      hope that what they learn will allow them to better care for infertile women in the future.
    

Detailed Description

      As part of this study, you will be asked to fill out a series of questionnaires. These
      questions will ask about your feelings, sexual function, quality of life, and ideas about
      reproductive options. We will also ask some questions about you, your health, and your
      medical history. You can choose to answer these questions either at one of your doctor visits
      or over the telephone. You can decide the best way to complete this assessment.
    


Study Type

Observational


Primary Outcome

Investigate emotional, sexual functioning, reproductive concerns and QOL experience of 3 groups of infertile women: gynecologic cancer survivors, survivors of hematological malignancies, & the non-cancer infertile women awaiting 3rd party reproduction

Secondary Outcome

 Assess and describe the attitudes towards, knowledge of, and utilization of third party reproduction of the study participants (cancer and non-cancer infertile groups)

Condition

Cervical Cancer

Intervention

survey instrument

Study Arms / Comparison Groups

 1
Description:  gynecologic cancer survivors

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Behavioral

Estimated Enrollment

179

Start Date

September 2006

Completion Date

June 2015

Primary Completion Date

June 2015

Eligibility Criteria

        Inclusion Criteria:

        Study group of gynecologic cancer survivors and BMT/SMT cancer survivors:

          -  History of a primary diagnosis of gynecologic cancer or history of any primary
             malignancy treated with BMT/SCT

          -  No evidence of disease for at least one year

          -  At least 18 years of age not greater than 49 years of age at time of study recruitment

          -  No other cancer history

          -  Have impaired fertility: lack of uterus but intact ovaries or lack of ovaries or lack
             of ovarian function based on the FSH determination but intact uterus

          -  Have not started or have not completed childbearing

          -  Able and willing to provide informed consent

          -  Ability to comprehend and complete questionnaire in English

        Comparison Group of non-cancer infertile women awaiting egg (oocyte) donation:

          -  No cancer history

          -  At least 18 years of age not greater than 49 years of age at time of study recruitment

          -  In ovarian failure and on a waiting list for egg (oocyte) donation

          -  Have not started or have not completed childbearing

          -  Able and willing to provide informed consent

          -  Ability to comprehend and complete questionnaire in English

        Exclusion Criteria:

          -  Inability to participate in an informed consent process

          -  Patients with a psychiatric disorder precluding response to the survey
      

Gender

Female

Ages

18 Years - 49 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Jeanne Carter, PhD, , 

Location Countries

United States

Location Countries

United States

Administrative Informations


NCT ID

NCT00581646

Organization ID

06-110


Responsible Party

Sponsor

Study Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

 New York Presbyterian Hospital

Study Sponsor

Jeanne Carter, PhD, Principal Investigator, Memorial Sloan Kettering Cancer Center


Verification Date

July 2015